Skip to main content
. 2019 Jul 22;9:10572. doi: 10.1038/s41598-019-46819-z

Figure 4.

Figure 4

Kaplan-Meier survival curve illustrating poor prognosis in patients with lower expression of SSBP2 although it did not reach statistical significance (median OS, 29.8 months vs. 42.3 months for low and high expressions respectively, HR 1.886, 95% CI 0.812–4.378, p = 0.140). Low and high immunoreactivity scores were 0–3 and 4–9, respectively.